| Literature DB >> 30906687 |
Yoshio Nakata1, Hiroyuki Sasai2, Takehiko Tsujimoto3, Koichi Hashimoto4, Hiroyuki Kobayashi4.
Abstract
The present study examined whether a web-based intervention could promote weight-loss maintenance, after weight loss. The study was a two-phase, 27-month, randomized controlled trial conducted in Ibaraki, Japan, from 2014 to 2017; 133 participants were recruited through local newspaper advertisements. The eligibility criteria were as follows: age of 40-64 years, body mass index of 25-40 kg/m2, and having at least one metabolic syndrome component. In phase 1, a 3-month, group-based weight-loss program was provided to all eligible participants (n = 119). We then randomly assigned (1:1) participants who had lost 5% or more of their weight during phase 1 (n = 95) to either the self-help (mean 3-month weight loss 7.30 kg) or the web-support group (7.00 kg). Participants in the web-support group regularly reported their body weight and physical activity through a web-based system. They received monthly personalized feedback from a study staff for 24 months. The primary outcome, 27-month body-weight change (mean ± standard deviation), in the self-help and web-support groups were - 5.3 ± 5.0 kg and -4.5 ± 4.9 kg, respectively. There was no significant difference. An exploratory secondary analysis demonstrated that those with greater 27-month increases in their step count, assessed with an accelerometer, lost more weight with no difference in changes in energy intake. The mean 27-month body-weight change in the 4th quartile of changes in step count was -7.78 kg. Although web-based intervention using an activity monitor failed to promote weight-loss maintenance, increased physical activity was associated with successful weight-loss maintenance.Entities:
Keywords: BMI, body mass index; Body weight changes; CI, confidence interval; Diet; Exercise; FG, food group; HDL, high-density lipoprotein; ITT, intention-to-treat; MET, metabolic equivalents; MVPA, moderate-to-vigorous physical activity; Obesity management; RCT, randomized controlled trial; SD, SansDisk; UMIN, University Hospital Medical Information Network; USB, Universal Serial Bus
Year: 2019 PMID: 30906687 PMCID: PMC6411634 DOI: 10.1016/j.pmedr.2019.100839
Source DB: PubMed Journal: Prev Med Rep ISSN: 2211-3355
Fig. 1Web-based system using weight scale and activity monitor (Ibaraki, Japan, 2014–2017).
Fig. 2Participant flowchart: intention-to-treat (ITT) (Ibaraki, Japan, 2014–2017).
Baseline characteristics of intervention participants (n = 95) (Ibaraki, Japan, 2014–2017).
| Characteristic | Self-help group ( | Web-support group ( |
|---|---|---|
| Demographics and lifestyle | ||
| Age, years | 57.0 (5.7) | 54.7 (6.6) |
| Female gender, | 30 (62.5) | 29 (61.7) |
| Current smoking, | 3 (6.2) | 2 (4.3) |
| Medication use | ||
| Antihypertensive, | 17 (35.4) | 17 (36.2) |
| Lipid-lowering, | 14 (29.2) | 11 (23.4) |
| Hypoglycemic, | 1 (2.1) | 1 (2.1) |
| Anthropometrics | ||
| Height, cm | 162.2 (8.1) | 162.2 (8.3) |
| Weight, kg | 74.2 (8.1) | 74.7 (10.6) |
| 3-month weight change, kg | −7.30 (−8.03, −6.57) | −7.00 (−7.62, −6.38) |
| Body mass index, kg/m2 | 28.2 (2.4) | 28.4 (3.1) |
| Waist circumference, cm | 98.6 (6.3) | 98.8 (7.4) |
| Blood pressure | ||
| Systolic, mm Hg | 138.7 (14.6) | 136.8 (16.5) |
| Diastolic, mm Hg | 87.8 (9.6) | 84.5 (10.5) |
| Blood biochemistry | ||
| Triglycerides, mg/dL | 132.3 (92.9) | 127.3 (103.9) |
| HDL cholesterol, mg/dL | 58.3 (15.9) | 57.2 (15.3) |
| Fasting plasma glucose, mg/dL | 102.3 (26.3) | 97.3 (11.4) |
| Energy intake and physical activity | ||
| Total energy intake, kcal/day | 1993 (407) | 2039 (398) |
| Valid days, day | 13.6 (1.8) | 13.6 (1.5) |
| Wear time, min/day | 929.9 (73.6) | 943.0 (85.7) |
| Step count, steps/day | 6167 (2409) | 6246 (2689) |
| MVPA, min/day | 57.2 (25.2) | 57.5 (30.3) |
Notes: Data are expressed as mean (standard deviation) for baseline values and as mean (95% confidence interval) for 3-month changes, unless otherwise specified.
Abbreviations: HDL, high-density lipoprotein; MVPA, moderate-to-vigorous physical activity.
Changes in body weight and metabolic syndrome components over 27 months (n = 95) (Ibaraki, Japan, 2014–2017).
| Characteristic | Self-help group ( | Web-support group ( | |
|---|---|---|---|
| Anthropometrics | |||
| Weight, kg | −5.30 (−6.76, −3.84) | −4.50 (−5.93, −3.07) | 0.43 |
| Weight loss ≥5%, | 28 (58.3) | 26 (55.3) | 0.93 |
| Body mass index, kg/m2 | −1.97 (−2.51, −1.44) | −1.74 (−2.28, −1.19) | 0.53 |
| Waist circumference, cm | −5.40 (−6.96, −3.84) | −4.54 (−5.85, −3.22) | 0.40 |
| Blood pressure | |||
| Systolic, mm Hg | −0.22 (−4.66, 4.22) | 0.49 (−3.37, 4.35) | 0.81 |
| Diastolic, mm Hg | −2.30 (−5.06, 0.45) | −1.09 (−3.31, 1.14) | 0.49 |
| Blood biochemistry | |||
| Triglycerides, mg/dL | −29.2 (−47.5, −10.9) | −18.8 (−34.3, −3.3) | 0.38 |
| HDL cholesterol, mg/dL | 4.44 (2.17, 6.70) | 4.30 (1.53, 7.06) | 0.94 |
| Fasting plasma glucose, mg/dL | −4.98 (−9.22, −0.74) | −0.40 (−3.07, 2.26) | 0.07 |
| Energy intake and physical activity | |||
| Total energy intake, kcal/day | −264.9 (−374.6, −155.2) | −314.4 (−433.5, −195.3) | 0.54 |
| Step count, steps/day | 33.5 (−485.7, 552.7) | 532.5 (−71.5, 1136.5) | 0.21 |
| MVPA, min/day | −0.34 (−6.46, 5.77) | 3.62 (−3.09, 10.34) | 0.38 |
Notes: Data expressed as mean (95% confidence interval) unless specified. Invalid data on physical activity (n = 4) were replaced by their baseline values.
Abbreviations: HDL, high-density lipoprotein; MVPA, moderate-to-vigorous physical activity.
Fig. 3Pattern of change in body weight by group assignment. Each data point indicates the mean value of all randomized participants, with missing values imputed by baseline observations carried forward. Error bars indicate standard errors (Ibaraki, Japan, 2014–2017).
Baseline characteristics and 27-month changes in outcome measures according to the quartiles of change in step count (n = 81) (Ibaraki, Japan, 2014–2017).
| Characteristic | 27-month change in step count | ||||
|---|---|---|---|---|---|
| 1st quartile (≤−860 steps, | 2nd quartile (−860–325 steps, | 3rd quartile (325–1626 steps, | 4th quartile (≥1626 steps, | ||
| Age, years | 56.5 (5.4) | 56.0 (6.0) | 57.0 (6.2) | 55.2 (7.4) | 0.82 |
| Female, | 13 (61.9) | 13 (65.0) | 12 (60.0) | 12 (60.0) | 0.99 |
| Web-support group, | 8 (38.1) | 7 (35.0) | 10 (50.0) | 11 (55.0) | 0.53 |
| Current smoking, | 1 (4.8) | 1 (5.0) | 2 (10.0) | 0 (0.0) | 0.55 |
| Antihypertensive medication, | 10 (47.6) | 7 (35.0) | 5 (25.0) | 7 (35.0) | 0.51 |
| Lipid-lowering medication, | 9 (42.9) | 2 (10.0) | 4 (20.0) | 8 (40.0) | 0.06 |
| Hypoglycemic medication, | 1 (4.8) | 1 (5.0) | 0 (0.0) | 0 (0.0) | 0.57 |
| Height, cm | 161.8 (8.9) | 160.2 (8.6) | 163.4 (7.0) | 162.6 (8.4) | 0.65 |
| Weight, kg | |||||
| Baseline | 70.9 (7.6) | 73.3 (10.1) | 75.6 (10.6) | 76.0 (9.1) | 0.28 |
| Change | −4.34 (−6.02, −2.67) | −4.02 (−5.97, −2.06) | −6.88 (−9.51, −4.25) | −7.78 (−9.48, −6.08) | 0.02 |
| Loss of ≥5%, n (%) | 11 (52.4) | 10 (50.0) | 13 (65.0) | 18 (90.0) | 0.03 |
| Body mass index, kg/m2 | |||||
| Baseline | 27.1 (1.7) | 28.5 (3.1) | 28.2 (2.8) | 28.7 (2.4) | 0.16 |
| Change | −1.65 (−2.26, −1.03) | −1.49 (−2.20, −0.79) | −2.55 (−3.52, −1.59) | −3.00 (−3.71, −2.28) | 0.01 |
| Waist circumference, cm | |||||
| Baseline | 96.7 (5.7) | 98.2 (7.1) | 99.3 (6.3) | 98.6 (4.3) | 0.53 |
| Change | −4.39 (−6.25, −2.53) | −4.94 (−7.41, −2.46) | −6.76 (−9.14, −4.38) | −7.11 (−9.17, −5.05) | 0.19 |
| Systolic blood pressure, mm Hg | |||||
| Baseline | 138.0 (16.6) | 142.1 (17.4) | 139.8 (12.8) | 134.9 (11.7) | 0.48 |
| Change | 0.90 (−7.33, 9.14) | −1.42 (−6.83, 3.98) | −0.40 (−5.50, 4.70) | 1.90 (−4.69, 8.49) | 0.88 |
| Diastolic blood pressure, mm Hg | |||||
| Baseline | 87.0 (9.8) | 87.4 (10.4) | 84.5 (7.5) | 87.5 (9.3) | 0.73 |
| Change | −0.19 (−5.09, 4.71) | −2.92 (−7.18, 1.33) | −2.60 (−5.40, 0.20) | −2.62 (−6.35, 1.10) | 0.72 |
| Triglycerides, mg/dL | |||||
| Baseline | 115.3 (47.8) | 137.1 (143.0) | 128.0 (119.6) | 157.9 (81.3) | 0.61 |
| Change | −24.6 (−41.2, −8.0) | −14.9 (−42.2, 12.3) | −29.5 (−61.9, 2.9) | −48.0 (−81.5, −14.4) | 0.37 |
| HDL cholesterol, mg/dL | |||||
| Baseline | 60.6 (15.6) | 55.8 (13.9) | 59.4 (17.6) | 52.4 (11.4) | 0.29 |
| Change | 4.67 (0.07, 9.26) | 4.20 (1.20, 7.20) | 4.65 (1.02, 8.28) | 7.45 (2.81, 12.09) | 0.63 |
| Fasting plasma glucose, mg/dL | |||||
| Baseline | 100.3 (37.2) | 104.0 (17.3) | 97.5 (10.0) | 99.7 (11.7) | 0.83 |
| Change | −6.43 (−14.65, 1.80) | 0.90 (−4.09, 5.89) | −3.15 (−7.69, 1.39) | −4.20 (−9.66, 1.26) | 0.34 |
| Total energy intake, kcal/day | |||||
| Baseline | 1975 (359) | 2130 (513) | 1977 (479) | 1988 (332) | 0.60 |
| Change | −281.5 (−468.3, −94.6) | −429.9 (−663.2, −196.7) | −308.5 (−462.4, −154.7) | −257.7 (−412.3, −103.0) | 0.53 |
| Step count, steps/day | |||||
| Baseline | 8065 (2426) | 5560 (2234) | 5612 (1758) | 5920 (3105) | 0.003 |
| Change | −2202 (−2765, −1640) | −289 (−472, −105) | 928 (742, 1115) | 3005 (2519, 3490) | <0.001 |
| MVPA, min/day | |||||
| Baseline | 76.2 (22.5) | 52.7 (25.7) | 51.2 (25.6) | 55.4 (29.3) | 0.008 |
| Change | −20.9 (−29.6, −12.3) | 0.2 (−7.2, 7.6) | 0.6 (−5.4, 6.5) | 28.9 (21.7, 36.2) | <0.001 |
Notes: Data expressed as mean (standard deviation) for baseline values and as mean (95% confidence interval) for 27-month changes, unless otherwise specified.
Abbreviations: HDL, high-density lipoprotein; MVPA, moderate-to-vigorous physical activity.